MKI67 and hepatocellular carcinoma: Decreased tumor cell proliferation through a reduction in Ki-67 and the inhibition of β-catenin [81] was reported in hepatocellular carcinoma cells treated with amitriptyline, while in glioblastoma multiforme (GBM), amitriptyline induced cell death by interfering with mitochondrial function [82].